The MAPK signaling pathway mediates the GPR91-dependent release of VEGF from RGC-5 cells

International Journal of Molecular Medicine

Volumn 36, Issue 1, 2015, Pages 130-138

  Hu, Jianyan ^a   Li, Tingting ^a   Du, Shanshan ^a   Chen, Yongdong ^a   Wang, Shuai ^a   Xiong, Fen ^a   Wu, Qiang ^a,b  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b Shanghai Key Laboratory of Diabetes Mellitus   (China)

Author keywords

Cyclooxygenase 2; Diabetic retinopathy; G protein coupled receptor 91; Mitogen activated protein kinase signaling pathway; Prostaglandin E2; Small hairpin RNA; Vascular endothelial growth factor

Indexed keywords

G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 91; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PROSTAGLANDIN E2; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG; VASCULOTROPIN; CYCLOOXYGENASE 2; GPR91 PROTEIN, RAT; PTGS2 PROTEIN, RAT; SMALL INTERFERING RNA; VASCULAR ENDOTHELIAL GROWTH FACTOR A, RAT; VASCULOTROPIN A;

ANIMAL CELL; ARTICLE; CELL COUNTING; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REGULATORY MECHANISM; RETINA GANGLION CELL; SIGNAL TRANSDUCTION; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CELL LINE; CELL PROLIFERATION; DIABETES MELLITUS; DIABETIC RETINOPATHY; ENZYME ACTIVATION; GENETICS; METABOLISM; PATHOLOGY; RAT; RHESUS MONKEY; RNA INTERFERENCE; SECRETION (PROCESS);

ANIMALS; CELL LINE; CELL PROLIFERATION; CYCLOOXYGENASE 2; DIABETES COMPLICATIONS; DIABETIC RETINOPATHY; DINOPROSTONE; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MACACA MULATTA; MAP KINASE SIGNALING SYSTEM; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RATS; RECEPTORS, G-PROTEIN-COUPLED; RETINAL GANGLION CELLS; RNA INTERFERENCE; RNA, SMALL INTERFERING; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84930317464     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2015.2195     Document Type: Article

References (50)

1. Nolan CJ, Damm P and Prentki M: Type 2 diabetes across generations: from pathophysiology to prevention and management. Lancet 378: 169-181, 2011.
2. Witmer AN, Blaauwgeers HG, Weich HA, Alitalo K, Vrensen GF and Schlingemann RO: Altered expression patterns of VEGF receptors in human diabetic retina and in experimental VEGF-induced retinopathy in monkey. Invest Ophthalmol Vis Sci 43: 849-857, 2002.
3. Zheng Z, Chen H, Wang H, et al: Improvement of retinal vascular injury in diabetic rats by Statins is associated with the inhibition of mitochondrial reactive oxygen species pathway mediated by peroxisome proliferator-activated receptor coactivator 1. Diabetes 59: 2315-2325, 2010.
4. Neufeld G, Cohen T, Gengrinovitch S and Poltorak Z: Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 13: 9-22, 1999.
5. Duh E and Aiello LP: Vascular endothelial growth factor and diabetes: the agonist versus antagonist paradox. Diabetes 48: 1899-1906, 1999.
6. Dahrouj M, Alsarraf O, McMillin JC, Liu Y, Crosson CE and Ablonczy Z: Vascular endothelial growth factor modulates the function of the retinal pigment epithelium in vivo. Invest Ophthalmol Vis Sci 55: 2269-2275, 2014.
7. Krizova D, Vokrojova M, Liehneova K and Studeny P: Treatment of corneal neovascularization using anti-VEGF Bevacizumab. J Ophthalmol 2014: 178132, 2014.
8. Sapieha P, Sirinyan M, Hamel D, et al: The succinate receptor GPR91 in neurons has a major role in retinal angiogenesis. Nat Med 14: 1067-1076, 2008.
9. He W, Miao FJ, Lin DC, et al: Citric acid cycle intermediates as ligands for orphan G-protein-coupled receptors. Nature 429: 188-193, 2004.
10. Li T, Hu J, Du S, Chen Y, Wang S and Wu Q: ERK1/2/COX-2/PGE2 signaling pathway mediates GPR91-dependent VEGF release in streptozotocin-induced diabetes. Mol Vis 20: 1109-1121, 2014.
11. Correa PR, Kruglov EA, Thompson M, Leite MF, Dranoff JA and Nathanson MH: Succinate is a paracrine signal for liver damage. J Hepatol 47: 262-269, 2007.
12. 2+ transient and cardiomyocyte viability through PKA-dependent pathway. Cell Calcium 47: 37-46, 2010.
13. Rubic T, Lametschwandtner G, Jost S, et al: Triggering the succinate receptor GPR91 on dendritic cells enhances immunity. Nat Immunol 9: 1261-1269, 2008.
14. Robben JH, Fenton RA, Vargas SL, Schweer H, Peti-Peterdi J, Deen PM and Milligan G: Localization of the succinate receptor in the distal nephron and its signaling in polarized MDCK cells. Kidney Int 76: 1258-1267, 2009.
15. Matsumoto M, Suzuma K, Maki T, Kinoshita H, Tsuiki E, Fujikawa A and Kitaoka T: Succinate increases in the vitreous fluid of patients with active proliferative diabetic retinopathy. Am J Ophthalmol 153: 896-902.e1, 2012.
16. Hu J, Wu Q, Li T, Chen Y and Wang S: Inhibition of high glucose-induced VEGF release in retinal ganglion cells by RNA interference targeting G protein-coupled receptor 91. Exp Eye Res 109: 31-39, 2013.
17. Toma I, Kang JJ, Sipos A, et al: Succinate receptor GPR91 provides a direct link between high glucose levels and renin release in murine and rabbit kidney. J Clin Invest 118: 2526-2534, 2008.
18. Vargas SL, Toma I, Kang JJ, Meer EJ and Peti-Peterdi J: Activation of the succinate receptor GPR91 in macula densa cells causes renin release. J Am Soc Nephrol 20: 1002-1011, 2009.
19. 3 receptors expressed in Chinese hamster ovary cells all mediate the phosphorylation of extracellular-regulated kinase 1/2. Mol Pharmacol 58: 477-482, 2000.
20. Yoon S and Seger R: The extracellular signal-regulated kinase: multiple substrates regulate diverse cellular functions. Growth Factors 24: 21-44, 2006.
21. Zhang W and Liu HT: MAPK signal pathways in the regulation of cell proliferation in mammalian cells. Cell Res 12: 9-18, 2002.
22. Raman M, Chen W and Cobb MH: Differential regulation and properties of MAPKs. Oncogene 26: 3100-3112, 2007.
23. Lee JJ, Hsiao CC, Yang IH, et al: High-mobility group box 1 protein is implicated in advanced glycation end products-induced vascular endothelial growth factor A production in the rat retinal ganglion cell line RGC-5. Mol Vis 18: 838-850, 2012.
24. Adachi T, Teramachi M, Yasuda H, Kamiya T and Hara H: Contribution of p38 MAPK, NF-kappaB and glucocorticoid signaling pathways to ER stress-induced increase in retinal endothelial permeability. Arch Biochem Biophys 520: 30-35, 2012.
25. Du Y, Tang J, Li G, et al: Effects of p38 MAPK inhibition on early stages of diabetic retinopathy and sensory nerve function. Invest Ophthalmol Vis Sci 51: 2158-2164, 2010.
26. Ayalasomayajula SP, Amrite AC and Kompella UB: Inhibition of cyclooxygenase-2, but not cyclooxygenase-1, reduces prostaglandin E2 secretion from diabetic rat retinas. Eur J Pharmacol 498: 275-278, 2004.
27. Xin X, Majumder M, Girish GV, Mohindra V, Maruyama T and Lala PK: Targeting COX-2 and EP4 to control tumor growth, angiogenesis, lymphangiogenesis and metastasis to the lungs and lymph nodes in a breast cancer model. Lab Invest 92: 1115-1128, 2012.
28. Zhou LH, Hu Q, Sui H, et al: Tanshinone II-a inhibits angiogenesis through down regulation of COX-2 in human colorectal cancer. Asian Pac J Cancer Prev 13: 4453-4458, 2012.
29. 2, VEGF, and vascular leakage. Invest Ophthalmol Vis Sci 47: 1149-1160, 2006.
30. Tan Y, Ichikawa T, Li J, et al: Diabetic downregulation of Nrf2 activity via ERK contributes to oxidative stress-induced insulin resistance in cardiac cells in vitro and in vivo. Diabetes 60: 625-633, 2011.
31. Nakabayashi H and Shimizu K: HA1077, a Rho kinase inhibitor, suppresses glioma-induced angiogenesis by targeting the Rho-ROCK and the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase (MEK/ERK) signal pathways. Cancer Sci 102: 393-399, 2011.
32. Dhanasekaran DN and Reddy EP: JNK signaling in apoptosis. Oncogene 27: 6245-6251, 2008.
33. Cuadrado A and Nebreda AR: Mechanisms and functions of p38 MAPK signalling. Biochem J 429: 403-417, 2008.
34. Campo GM, Avenoso A, D'Ascola A, et al: 4-mer hyaluronan oligosaccharides stimulate inflammation response in synovial fibroblasts in part via TAK-1 and in part via p38-MAPK. Curr Med Chem 20: 1162-1172, 2013.
35. Michler T, Storr M, Kramer J, et al: Activation of cannabinoid receptor 2 reduces inflammation in acute experimental pancreatitis via intra-acinar activation of p38 and MK2-dependent mechanisms. Am J Physiol Gastrointest Liver Physiol 304: G181-G192, 2013.
36. Pollard PJ, Wortham NC and Tomlinson IP: The TCA cycle and tumorigenesis: the examples of fumarate hydratase and succinate dehydrogenase. Ann Med 35: 632-639, 2003.
37. Buzzi N, Bilbao PS, Boland R and de Boland AR: Extracellular ATP activates MAP kinase cascades through a P2Y purinergic receptor in the human intestinal Caco-2 cell line. Biochim Biophys Acta 1790: 1651-1659, 2009.
38. Kern TS: Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy. Exp Diabetes Res 2007: 95103, 2007.
39. Neroev VV, Zueva MV and Kalamkarov GR: Molecular mechanisms of retinal ischemia. Vestn Oftalmol 126: 59-64, 2010 (In Russian).
40. Patel N: Targeting leukostasis for the treatment of early diabetic retinopathy. Cardiovasc Hematol Disord Drug Targets 9: 222-229, 2009.
41. Nagoya H, Futagami S, Shimpuku M, et al: Apurinic/apyrimidinic endonuclease-1 is associated with angiogenesis and VEGF production via upregulation of COX-2 expression in esophageal cancer tissues. Am J Physiol Gastrointest Liver Physiol 306: G183-G190, 2014.
42. 2 receptor EP4 in pathologic ocular angiogenesis. Invest Ophthalmol Vis Sci 50: 5479-5486, 2009.
43. Inoue H, Takamori M, Nagata N, Nishikawa T, Oda H, Yamamoto S and Koshihara Y: An investigation of cell proliferation and soluble mediators induced by interleukin 1beta in human synovial fibroblasts: comparative response in osteoarthritis and rheumatoid arthritis. Inflamm Res 50: 65-72, 2001.
44. Höper MM, Voelkel NF, Bates TO, Allard JD, Horan M, Shepherd D and Tuder RM: Prostaglandins induce vascular endothelial growth factor in a human monocytic cell line and rat lungs via cAMP. Am J Respir Cell Mol Biol 17: 748-756, 1997.
45. 2 induces vascular endothelial growth factor and basic fibroblast growth factor mRNA expression in cultured rat Muller cells. Invest Ophthalmol Vis Sci 39: 581-591, 1998.
46. Zhong X, Wang H and Jian X: Insulin augments mechanical strain-induced ERK activation and cyclooxygenase-2 expression in MG63 cells through integrins. Exp Ther Med 7: 295-299, 2014.
47. Chuang YF, Yang HY, Ko TL, Hsu YF, Sheu JR, Ou G and Hsu MJ: Valproic acid suppresses lipopolysaccharide-induced cyclooxygenase-2 expression via MKP-1 in murine brain microvascular endothelial cells. Biochem Pharmacol 88: 372-383, 2014.
48. Amrite A, Pugazhenthi V, Cheruvu N and Kompella U: Delivery of celecoxib for treating diseases of the eye: influence of pigment and diabetes. Expert Opin Drug Deliv 7: 631-645, 2010.
49. Ferrara N and Davis-Smyth T: The biology of vascular endothelial growth factor. Endocr Rev 18: 4-25, 1997.
50. Li F, Xu H, Zeng Y and Yin ZQ: Overexpression offibulin-5 in retinal pigment epithelial cells inhibits cell proliferation and migration and downregulates VEGF, CXCR4, and TGFB1 expression in cocultured choroidal endothelial cells. Cur Eye Res 37: 540-548, 2012.